Literature DB >> 9365220

Subtypes of the muscarinic receptor in smooth muscle.

F J Ehlert1, R S Ostrom, G W Sawyer.   

Abstract

Muscarinic receptors are expressed in smooth muscle throughout the body. In most instances, the muscarinic receptor population in smooth muscle is composed of mainly the M2 and M3 subtypes in an 80% to 20% mixture. The M3 subtype mediates phosphoinositide hydrolysis and calcium mobilization, whereas the M2 subtype mediates an inhibition of cAMP accumulation. In addition, a variety of ionic conductances are elicited by muscarinic receptors. Muscarinic agonists stimulate a nonselective cation conductance that is pertussis toxin-sensitive and dependent on calcium. The pertussis toxin-sensitivity of this response suggests that it is mediated by M2 receptors. Following agonist induced depolarization of smooth muscle, voltage dependent calcium channels are activated to enable an influx of calcium. In some instances, muscarinic agonists enhance this conductance through a mechanism involving protein kinase C, whereas in other instances, muscarinic agonists suppress this calcium conductance. Smooth muscle often contains calcium activated potassium channels that tend to repolarize the membrane following calcium influx. Activation of muscarinic receptors suppresses this potassium conductance in some smooth muscles. Under standard conditions, muscarinic agonists elicit pertussis toxin-insensitive contractions through activation of the M3 receptor. When most of the M3 receptors are inactivated, it is possible to measure a pertussis toxin-sensitive contractile response to muscarinic agonists that is most likely mediated through M2 receptors. M2 receptors also cause an indirect contraction by inhibiting the relaxant effects of agents that increase cAMP (e.g., forskolin and isoproterenol).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365220     DOI: 10.1016/s0024-3205(97)00433-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Acupuncture at heterotopic acupoints enhances jejunal motility in constipated and diarrheic rats.

Authors:  Qing-Guang Qin; Xin-Yan Gao; Kun Liu; Xiao-Chun Yu; Liang Li; Hai-Ping Wang; Bing Zhu
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Muscarinic acetylcholine receptor compounds alter net Ca2+ flux and contractility in an invertebrate smooth muscle.

Authors:  C Leah Devlin; William Amole; Shawn Anderson; Kyle Shea
Journal:  Invert Neurosci       Date:  2003-03-18

3.  Functional role of muscarinic M(2) receptors in alpha,beta-methylene ATP induced, neurogenic contractions in guinea-pig ileum.

Authors:  G W Sawyer; G Lambrecht; F J Ehlert
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Human bronchial smooth muscle cells express adenylyl cyclase isoforms 2, 4, and 6 in distinct membrane microdomains.

Authors:  Amy S Bogard; Congfeng Xu; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

5.  Effect of ileo-jejunal transposition on ileal longitudinal smooth muscle contractility in vitro in rats.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Munenori Nagao; Hiroo Naito; Michiaki Unno; Ken-ichi Shiiba; Seiki Matsuno; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

Review 6.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

7.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

Review 8.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

9.  Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.

Authors:  Scott R Armstrong; Sergio Briones; Brian Horger; Carrie L Richardson; Sarah Jaw-Tsai; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-07       Impact factor: 3.000

10.  Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells.

Authors:  Takashi Sakamoto; Toshihiro Unno; Takio Kitazawa; Tetsuro Taneike; Masahisa Yamada; Jürgen Wess; Masakazu Nishimura; Seiichi Komori
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.